Trial · NCT03213665
Adverse events125
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 125
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Treatment (Tazemetostat) | 9 | 20 | |
| other | Eosinophilia | Blood and lymphatic system disorders | Treatment (Tazemetostat) | 2 | 20 | |
| other | Thrombotic thrombocytopenic purpura | Blood and lymphatic system disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Palpitations | Cardiac disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Sinus bradycardia | Cardiac disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Sinus tachycardia | Cardiac disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Cushingoid | Endocrine disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Endocrine disorders - Other, specify | Endocrine disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Hypothyroidism | Endocrine disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Abdominal distension | Gastrointestinal disorders | Treatment (Tazemetostat) | 2 | 20 | |
| other | Abdominal pain | Gastrointestinal disorders | Treatment (Tazemetostat) | 6 | 20 | |
| other | Constipation | Gastrointestinal disorders | Treatment (Tazemetostat) | 2 | 20 | |
| other | Diarrhea | Gastrointestinal disorders | Treatment (Tazemetostat) | 3 | 20 | |
| other | Dry mouth | Gastrointestinal disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Dysphagia | Gastrointestinal disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Gastroesophageal reflux disease | Gastrointestinal disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Mucositis/stomatitis (functional/symptomatic) - Oral cavity | Gastrointestinal disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Nausea | Gastrointestinal disorders | Treatment (Tazemetostat) | 7 | 20 | |
| other | Stomach pain | Gastrointestinal disorders | Treatment (Tazemetostat) | 1 | 20 | |
| other | Vomiting | Gastrointestinal disorders | Treatment (Tazemetostat) | 9 | 20 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03213665/events